Published in Cancer Res on September 01, 1990
Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines. Br J Cancer (1995) 1.12
Fragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping. Chem Biol Drug Des (2010) 0.80
A novel class of lipophilic quinazoline-based folic acid analogues: cytotoxic agents with a folate-independent locus. Br J Cancer (1999) 0.80
Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specific roles in resistance to infection. J Exp Med (2001) 3.64
Melanoma excision by general practitioners in north-east Thames region, England. Br J Dermatol (1998) 2.84
Alzheimer's-disease-like changes in tau protein processing: association with aluminium accumulation in brains of renal dialysis patients. Lancet (1994) 2.74
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol Cell Biol (1997) 2.43
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol (2001) 2.41
The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res (2001) 2.17
Carbon assimilation by Pseudomonas oxalaticus (OXI). 4. Metabolism of oxalate in cell-free extracts of the organism grown on oxalate. Biochem J (1961) 2.04
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. Biochim Biophys Acta (2002) 1.98
ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study. Cancer Res (1991) 1.94
Carboplatin pharmacokinetics in children: the development of a pediatric dosing formula. The United Kingdom Children's Cancer Study Group. J Clin Oncol (1993) 1.93
CT differentiation of large abdominal lymphangioma from ascites. Pediatr Radiol (1993) 1.82
Ultrasonography and limited computed tomography in the diagnosis and management of appendicitis in children. JAMA (1999) 1.75
Posthaemorrhagic ventricular dilatation in the premature infant: natural history and predictors of outcome. Arch Dis Child Fetal Neonatal Ed (2002) 1.72
Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer (1996) 1.71
Alternatively spliced mdm2 transcripts with loss of p53 binding domain sequences: transforming ability and frequent detection in human cancer. Nat Med (1996) 1.68
Gamma interferon-induced inhibition of Toxoplasma gondii in astrocytes is mediated by IGTP. Infect Immun (2001) 1.66
Posttraumatic shock in children: CT findings associated with hemodynamic instability. Radiology (1992) 1.62
The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells. Mol Cell Biol (1999) 1.62
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61
Fluorinated pyrimidines and their nucleosides. Adv Enzymol Relat Areas Mol Biol (1983) 1.54
Carboplatin or cisplatin? Lancet (1988) 1.53
Effect of computed tomography on patient management and costs in children with suspected appendicitis. Pediatrics (1999) 1.53
Potentiation of temozolomide and topotecan growth inhibition and cytotoxicity by novel poly(adenosine diphosphoribose) polymerase inhibitors in a panel of human tumor cell lines. Clin Cancer Res (2000) 1.52
An investigation into school children's knowledge and awareness of food and nutrition. J Hum Nutr Diet (2002) 1.50
Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. Clin Sci (Lond) (1985) 1.47
Tumour necrosis factor in man: clinical and biological observations. Br J Cancer (1987) 1.46
Different effector cell types in antibody-dependent cell-mediated cytotoxicity. Nature (1975) 1.45
Sonographic evaluation of orthotopic bladder tumors in mice treated with TNP-470, an angiogenic inhibitor. Acad Radiol (2001) 1.44
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. Br J Cancer (2001) 1.42
Analysis of regional cerebral blood flow in dogs, with an experimental microbubble-based US contrast agent. Radiology (1996) 1.42
Commentary: emergency department sonography in the initial evaluation of blunt abdominal injury in children. Pediatr Radiol (1993) 1.41
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717. J Clin Oncol (1986) 1.40
A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis. J Biol Chem (1989) 1.39
Phase I and pharmacokinetic studies with the pentacyclic pyrroloquinone mitoquidone. Cancer Chemother Pharmacol (1988) 1.38
A dideazatetrahydrofolate analogue lacking a chiral center at C-6, N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7H-pyrrolo[2,3-d]pyrimidin-5- yl)ethyl]benzoyl]-L-glutamic acid, is an inhibitor of thymidylate synthase. J Med Chem (1992) 1.38
A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice. Eur J Cancer (1981) 1.35
Phase II study of JM8, a new platinum analog, in advanced ovarian carcinoma. Cancer Treat Rep (1983) 1.32
High dose carboplatin in the treatment of lung cancer and mesothelioma: a phase I dose escalation study. Eur J Cancer Clin Oncol (1987) 1.31
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. Cancer Res (1984) 1.29
O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma. Br J Cancer (1998) 1.29
Promoter analysis of Zfp-36, the mitogen-inducible gene encoding the zinc finger protein tristetraprolin. J Biol Chem (1995) 1.25
Late-onset hemorrhagic cystitis associated with urinary excretion of polyomaviruses after bone marrow transplantation. Transplantation (1987) 1.23
Aminopeptidase A: a nephritogenic target antigen of nephrotoxic serum. Kidney Int (2001) 1.23
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies. Neurology (2000) 1.22
Visceral injury in battered children: a changing perspective. Radiology (1989) 1.21
The lap belt complex: intestinal and lumbar spine injury in children. J Trauma (1990) 1.21
Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer (1998) 1.19
In vivo kinetics of thymidylate synthetase inhibition of 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res (1982) 1.18
Estimation of glomerular filtration rate in cancer patients. Br J Cancer (2001) 1.16
Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis. J Natl Cancer Inst (1993) 1.15
Kinetically-based multiple drug treatment for advanced head and neck cancer. Br Med J (1975) 1.15
Blunt abdominal trauma in children: impact of CT on operative and nonoperative management. AJR Am J Roentgenol (1997) 1.14
Safety of one 52-mumol (50,000 IU) oral dose of vitamin A administered to neonates. Bull World Health Organ (1994) 1.14
Femoral appendicitis: an unusual case. Can J Surg (1989) 1.14
Promoting healthy diet and exercise patterns amongst primary school children: a qualitative investigation of parental perspectives. J Hum Nutr Diet (2003) 1.14
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. J Med Chem (2000) 1.13
Retrovirally mediated complementation of the glyB phenotype. Cloning of a human gene encoding the carrier for entry of folates into mitochondria. J Biol Chem (2000) 1.13
Blunt pancreatic trauma in children: CT diagnosis. AJR Am J Roentgenol (1992) 1.13
Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer (2003) 1.12
Phase I studies with carboplatin at the Royal Marsden Hospital. Cancer Treat Rev (1985) 1.11
Voiding cystourethrography: the initial radiologic study in children with urinary tract infection. Radiology (1985) 1.10
Antibody-dependent cell-mediated cytotoxicity in the rat. The role of macrophages. Immunology (1976) 1.10
Complementation mapping in microcell hybrids: localization of Fpgs and Ak-1 on Mus musculus chromosome 2. Somatic Cell Genet (1983) 1.10
Folate-based thymidylate synthase inhibitors as anticancer drugs. Ann Oncol (1995) 1.09
Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis. Oncogene (1998) 1.09
Problems in the chemotherapy of cancer in the neonate. Am J Pediatr Hematol Oncol (1981) 1.08
Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. J Clin Oncol (2002) 1.07
Routine chest radiographs in pediatric intensive care: a prospective study. Pediatrics (1989) 1.07
Folate metabolism in mammalian cells in culture. I Partial characterization of the folate derivatives present in L1210 mouse leukemia cells. J Biol Chem (1976) 1.07
Costs and effectiveness of ultrasonography and limited computed tomography for diagnosing appendicitis in children. Pediatrics (2000) 1.06
Resistance-modifying agents. 5. Synthesis and biological properties of quinazolinone inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase (PARP). J Med Chem (1998) 1.06
Thymidylate synthetase purified to homogeneity from human leukemic cells. Proc Natl Acad Sci U S A (1979) 1.04
Safety-belt injuries in children with lap-belt ecchymosis: CT findings in 61 patients. AJR Am J Roentgenol (1991) 1.04
Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. Melanoma Res (2002) 1.03
Resistance-modifying agents. 9. Synthesis and biological properties of benzimidazole inhibitors of the DNA repair enzyme poly(ADP-ribose) polymerase. J Med Chem (2000) 1.03
Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies. Eur J Cancer (2002) 1.03
Point mutations of the mtDNA control region in normal and neurodegenerative human brains. Am J Hum Genet (2000) 1.02
Hepatic and splenic injury in children: role of CT in the decision for laparotomy. Radiology (1987) 1.02
A retrograde labeling technique for the functional study of airway-specific visceral afferent neurons. J Neurosci Methods (1993) 1.02
Ten years' experience in the surgical treatment of basal-cell carcinoma. A study of factors associated with recurrence. Br J Surg (1973) 1.01
A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum Mol Genet (2001) 1.01
Blunt hepatic and splenic trauma in children: correlation of a CT injury severity scale with clinical outcome. Pediatr Radiol (1995) 1.01
Synthesis of the antileukemic agents 5,10-dideazaaminopterin and 5,10-dideaza-5,6,7,8-tetrahydroaminopterin. J Med Chem (1985) 1.01
Lethal chylothoraces due to superior vena caval thrombosis in infants. AJR Am J Roentgenol (1981) 1.01
Cisplatin/carboplatin cross-resistance in ovarian cancer. Br J Cancer (1989) 1.01
A simple procedure for the synthesis of high specific activity tritiated (6S)-5-formyltetrahydrofolate. Anal Biochem (1982) 1.00
Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase. Biochemistry (1991) 1.00
Phase II study of the antifolate N10-propargyl-5,8-dideazafolic acid (CB 3717) in advanced breast cancer. Eur J Cancer Clin Oncol (1988) 1.00
The value of CT in detecting bowel perforation in children after blunt abdominal trauma. AJR Am J Roentgenol (1989) 1.00
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem J (1992) 0.99
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience. Br J Cancer (1995) 0.99
Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. Bone (1986) 0.99
Weaning preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed (2003) 0.98
Identification of the major phosphorylation domain of murine mdr1b P-glycoprotein. Analysis of the protein kinase A and protein kinase C phosphorylation sites. J Biol Chem (1993) 0.98
Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Br J Clin Pharmacol (1983) 0.98
Pharmacokinetics of the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB3717) in the mouse. Cancer Treat Rep (1986) 0.97